What Researchers Did
Researchers retrospectively analyzed the clinical presentation, management, and outcomes of 21 patients who underwent cystectomy for refractory hemorrhagic cystitis at a single institution between 2000 and 2012.
What They Found
The study found that 81% (17 of 21) of patients were male with a median age of 77 years, and 81% had hemorrhagic cystitis due to prior radiation therapy for prostate cancer. Severe complications occurred in 42% (8 of 19) of patients, with a 90-day mortality rate of 16% (3 of 19), and 1- and 3-year overall survival rates were 84% and 52% respectively.
What This Means for Canadian Patients
Canadian patients facing refractory hemorrhagic cystitis, particularly after radiation therapy, should be aware that cystectomy is a complex procedure with high risks of severe complications and mortality. This information can help patients and their clinicians make informed decisions about this last-resort treatment option, emphasizing the need for careful patient selection and comprehensive pre-operative counseling.
Canadian Relevance
This study was conducted at a single institution outside of Canada, therefore it has no direct Canadian connection.
Study Limitations
The study's limitations include its retrospective, single-center design, small sample size of 21 patients, and relatively short median follow-up period.